← Back to patent-cliff list
CAS 10464-31-0
5-benzyl-5H-dibenzo[b,f]azepin-10(11H)-one
Codes: OXCA-009
Application context (from source-drug indications)
SeizureOxcarbazepine三叉神经痛OxcarbazepinePainOxcarbazepinePartial-onset seizureOxcarbazepineMultiple sclerosisOxcarbazepineEpilepsyOxcarbazepine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Oxcarbazepine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
o-toluidine→2-bromo-N,N-diethylbenzamide→2-(benzyl(o-tolyl)amino)-N,N-diethylbenzamide→5-benzyl-5H-dibenzo[b,f]azepin-10(11H)-one→5H-dibenzo[b,f]azepin-10(11H)-one
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.